Global Antihypertensive Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Publisher Name :
Date: 22-Oct-2018
No. of pages: 132

Scope of the Report:

This report focuses on the Antihypertensive in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Increase in blood pressure is measured in terms of systolic and diastolic blood pressure exerted by blood on the wall of artery and hence it is also termed as arterial hypertension. Reduction in blood pressure minimizes the risk of heart failure, ischaemic heart diseases, dementia and mortality due to hypertension.

Antihypertensives are the drugs that are used to treat high blood pressure. This type of drug alleviate the complications of stroke and myocardial infarction.

-

The worldwide market for Antihypertensive is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

- Pfizer

- Novartis

- Sanofi

- Merck

- Boehringer Ingelheim

- Lupin

- Johnson & Johnson

- Astra Zeneca

- Daiichi Sankyo

- Ranbaxy

Market Segment by Regions, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- South America (Brazil, Argentina, Colombia etc.)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- Diuretics

- Angiotensin receptor blockers (ARBs)

- Angiotensin converting enzyme (ACE) inhibitors

- Beta blockers

- Alpha blockers

- Calcium channel blockers

- Renin inhibitors

- Vasodilators

Market Segment by Applications, can be divided into

- Hosptial

- Clinic

- Home

There are 15 Chapters to deeply display the global Antihypertensive market.

Chapter 1, to describe Antihypertensive Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Antihypertensive, with sales, revenue, and price of Antihypertensive, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Antihypertensive, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Antihypertensive market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Antihypertensive sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Global Antihypertensive Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Table of Contents

1 Market Overview
1.1 Antihypertensive Introduction
1.2 Market Analysis by Type
1.2.1 Diuretics
1.2.2 Angiotensin receptor blockers (ARBs)
1.2.3 Angiotensin converting enzyme (ACE) inhibitors
1.2.4 Beta blockers
1.2.5 Alpha blockers
1.2.6 Calcium channel blockers
1.2.7 Renin inhibitors
1.2.8 Vasodilators
1.3 Market Analysis by Applications
1.3.1 Hosptial
1.3.2 Clinic
1.3.3 Home
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Business Overview
2.1.2 Antihypertensive Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Pfizer Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Novartis
2.2.1 Business Overview
2.2.2 Antihypertensive Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Novartis Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Sanofi
2.3.1 Business Overview
2.3.2 Antihypertensive Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Sanofi Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Merck
2.4.1 Business Overview
2.4.2 Antihypertensive Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Merck Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Boehringer Ingelheim
2.5.1 Business Overview
2.5.2 Antihypertensive Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Boehringer Ingelheim Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Lupin
2.6.1 Business Overview
2.6.2 Antihypertensive Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Lupin Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Johnson & Johnson
2.7.1 Business Overview
2.7.2 Antihypertensive Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Johnson & Johnson Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Astra Zeneca
2.8.1 Business Overview
2.8.2 Antihypertensive Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Astra Zeneca Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Daiichi Sankyo
2.9.1 Business Overview
2.9.2 Antihypertensive Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Daiichi Sankyo Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Ranbaxy
2.10.1 Business Overview
2.10.2 Antihypertensive Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Ranbaxy Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Antihypertensive Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Antihypertensive Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Antihypertensive Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Antihypertensive Manufacturer Market Share in 2017
3.3.2 Top 6 Antihypertensive Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Antihypertensive Market Analysis by Regions
4.1 Global Antihypertensive Sales, Revenue and Market Share by Regions
4.1.1 Global Antihypertensive Sales and Market Share by Regions (2013-2018)
4.1.2 Global Antihypertensive Revenue and Market Share by Regions (2013-2018)
4.2 North America Antihypertensive Sales and Growth Rate (2013-2018)
4.3 Europe Antihypertensive Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Antihypertensive Sales and Growth Rate (2013-2018)
4.5 South America Antihypertensive Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Antihypertensive Sales and Growth Rate (2013-2018)
5 North America Antihypertensive by Countries
5.1 North America Antihypertensive Sales, Revenue and Market Share by Countries
5.1.1 North America Antihypertensive Sales and Market Share by Countries (2013-2018)
5.1.2 North America Antihypertensive Revenue and Market Share by Countries (2013-2018)
5.2 United States Antihypertensive Sales and Growth Rate (2013-2018)
5.3 Canada Antihypertensive Sales and Growth Rate (2013-2018)
5.4 Mexico Antihypertensive Sales and Growth Rate (2013-2018)
6 Europe Antihypertensive by Countries
6.1 Europe Antihypertensive Sales, Revenue and Market Share by Countries
6.1.1 Europe Antihypertensive Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Antihypertensive Revenue and Market Share by Countries (2013-2018)
6.2 Germany Antihypertensive Sales and Growth Rate (2013-2018)
6.3 UK Antihypertensive Sales and Growth Rate (2013-2018)
6.4 France Antihypertensive Sales and Growth Rate (2013-2018)
6.5 Russia Antihypertensive Sales and Growth Rate (2013-2018)
6.6 Italy Antihypertensive Sales and Growth Rate (2013-2018)
7 Asia-Pacific Antihypertensive by Countries
7.1 Asia-Pacific Antihypertensive Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Antihypertensive Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Antihypertensive Revenue and Market Share by Countries (2013-2018)
7.2 China Antihypertensive Sales and Growth Rate (2013-2018)
7.3 Japan Antihypertensive Sales and Growth Rate (2013-2018)
7.4 Korea Antihypertensive Sales and Growth Rate (2013-2018)
7.5 India Antihypertensive Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Antihypertensive Sales and Growth Rate (2013-2018)
8 South America Antihypertensive by Countries
8.1 South America Antihypertensive Sales, Revenue and Market Share by Countries
8.1.1 South America Antihypertensive Sales and Market Share by Countries (2013-2018)
8.1.2 South America Antihypertensive Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Antihypertensive Sales and Growth Rate (2013-2018)
8.3 Argentina Antihypertensive Sales and Growth Rate (2013-2018)
8.4 Colombia Antihypertensive Sales and Growth Rate (2013-2018)
9 Middle East and Africa Antihypertensive by Countries
9.1 Middle East and Africa Antihypertensive Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Antihypertensive Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Antihypertensive Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Antihypertensive Sales and Growth Rate (2013-2018)
9.3 UAE Antihypertensive Sales and Growth Rate (2013-2018)
9.4 Egypt Antihypertensive Sales and Growth Rate (2013-2018)
9.5 Nigeria Antihypertensive Sales and Growth Rate (2013-2018)
9.6 South Africa Antihypertensive Sales and Growth Rate (2013-2018)
10 Global Antihypertensive Market Segment by Type
10.1 Global Antihypertensive Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Antihypertensive Sales and Market Share by Type (2013-2018)
10.1.2 Global Antihypertensive Revenue and Market Share by Type (2013-2018)
10.2 Diuretics Sales Growth and Price
10.2.1 Global Diuretics Sales Growth (2013-2018)
10.2.2 Global Diuretics Price (2013-2018)
10.3 Angiotensin receptor blockers (ARBs) Sales Growth and Price
10.3.1 Global Angiotensin receptor blockers (ARBs) Sales Growth (2013-2018)
10.3.2 Global Angiotensin receptor blockers (ARBs) Price (2013-2018)
10.4 Angiotensin converting enzyme (ACE) inhibitors Sales Growth and Price
10.4.1 Global Angiotensin converting enzyme (ACE) inhibitors Sales Growth (2013-2018)
10.4.2 Global Angiotensin converting enzyme (ACE) inhibitors Price (2013-2018)
10.5 Beta blockers Sales Growth and Price
10.5.1 Global Beta blockers Sales Growth (2013-2018)
10.5.2 Global Beta blockers Price (2013-2018)
10.6 Alpha blockers Sales Growth and Price
10.6.1 Global Alpha blockers Sales Growth (2013-2018)
10.6.2 Global Alpha blockers Price (2013-2018)
10.7 Calcium channel blockers Sales Growth and Price
10.7.1 Global Calcium channel blockers Sales Growth (2013-2018)
10.7.2 Global Calcium channel blockers Price (2013-2018)
10.8 Renin inhibitors Sales Growth and Price
10.8.1 Global Renin inhibitors Sales Growth (2013-2018)
10.8.2 Global Renin inhibitors Price (2013-2018)
10.9 Vasodilators Sales Growth and Price
10.9.1 Global Vasodilators Sales Growth (2013-2018)
10.9.2 Global Vasodilators Price (2013-2018)
11 Global Antihypertensive Market Segment by Application
11.1 Global Antihypertensive Sales Market Share by Application (2013-2018)
11.2 Hosptial Sales Growth (2013-2018)
11.3 Clinic Sales Growth (2013-2018)
11.4 Home Sales Growth (2013-2018)
12 Antihypertensive Market Forecast (2018-2023)
12.1 Global Antihypertensive Sales, Revenue and Growth Rate (2018-2023)
12.2 Antihypertensive Market Forecast by Regions (2018-2023)
12.2.1 North America Antihypertensive Market Forecast (2018-2023)
12.2.2 Europe Antihypertensive Market Forecast (2018-2023)
12.2.3 Asia-Pacific Antihypertensive Market Forecast (2018-2023)
12.2.4 South America Antihypertensive Market Forecast (2018-2023)
12.2.5 Middle East and Africa Antihypertensive Market Forecast (2018-2023)
12.3 Antihypertensive Market Forecast by Type (2018-2023)
12.3.1 Global Antihypertensive Sales Forecast by Type (2018-2023)
12.3.2 Global Antihypertensive Market Share Forecast by Type (2018-2023)
12.4 Antihypertensive Market Forecast by Application (2018-2023)
12.4.1 Global Antihypertensive Sales Forecast by Application (2018-2023)
12.4.2 Global Antihypertensive Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

List of Tables and Figures

Figure Antihypertensive Picture
Table Product Specifications of Antihypertensive
Figure Global Sales Market Share of Antihypertensive by Types in 2017
Table Antihypertensive Types for Major Manufacturers
Figure Diuretics Picture
Figure Angiotensin receptor blockers (ARBs) Picture
Figure Angiotensin converting enzyme (ACE) inhibitors Picture
Figure Beta blockers Picture
Figure Alpha blockers Picture
Figure Calcium channel blockers Picture
Figure Renin inhibitors Picture
Figure Vasodilators Picture
Figure Antihypertensive Sales Market Share by Applications in 2017
Figure Hosptial Picture
Figure Clinic Picture
Figure Home Picture
Figure United States Antihypertensive Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Antihypertensive Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Antihypertensive Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Antihypertensive Revenue (Value) and Growth Rate (2013-2023)
Figure France Antihypertensive Revenue (Value) and Growth Rate (2013-2023)
Figure UK Antihypertensive Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Antihypertensive Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Antihypertensive Revenue (Value) and Growth Rate (2013-2023)
Figure China Antihypertensive Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Antihypertensive Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Antihypertensive Revenue (Value) and Growth Rate (2013-2023)
Figure India Antihypertensive Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Antihypertensive Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Antihypertensive Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Antihypertensive Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Antihypertensive Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Antihypertensive Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Antihypertensive Revenue (Value) and Growth Rate (2013-2023)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Antihypertensive Type and Applications
Table Pfizer Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Antihypertensive Type and Applications
Table Novartis Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Antihypertensive Type and Applications
Table Sanofi Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Antihypertensive Type and Applications
Table Merck Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table Boehringer Ingelheim Antihypertensive Type and Applications
Table Boehringer Ingelheim Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Lupin Basic Information, Manufacturing Base and Competitors
Table Lupin Antihypertensive Type and Applications
Table Lupin Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Antihypertensive Type and Applications
Table Johnson & Johnson Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Astra Zeneca Basic Information, Manufacturing Base and Competitors
Table Astra Zeneca Antihypertensive Type and Applications
Table Astra Zeneca Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table Daiichi Sankyo Antihypertensive Type and Applications
Table Daiichi Sankyo Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Ranbaxy Basic Information, Manufacturing Base and Competitors
Table Ranbaxy Antihypertensive Type and Applications
Table Ranbaxy Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Antihypertensive Sales by Manufacturer (2016-2017)
Figure Global Antihypertensive Sales Market Share by Manufacturer in 2016
Figure Global Antihypertensive Sales Market Share by Manufacturer in 2017
Table Global Antihypertensive Revenue by Manufacturer (2016-2017)
Figure Global Antihypertensive Revenue Market Share by Manufacturer in 2016
Figure Global Antihypertensive Revenue Market Share by Manufacturer in 2017
Figure Top 3 Antihypertensive Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Antihypertensive Manufacturer (Revenue) Market Share in 2017
Figure Global Antihypertensive Sales and Growth Rate (2013-2018)
Figure Global Antihypertensive Revenue and Growth Rate (2013-2018)
Table Global Antihypertensive Sales by Regions (2013-2018)
Table Global Antihypertensive Sales Market Share by Regions (2013-2018)
Table Global Antihypertensive Revenue by Regions (2013-2018)
Figure Global Antihypertensive Revenue Market Share by Regions in 2013
Figure Global Antihypertensive Revenue Market Share by Regions in 2017
Figure North America Antihypertensive Sales and Growth Rate (2013-2018)
Figure Europe Antihypertensive Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Antihypertensive Sales and Growth Rate (2013-2018)
Figure South America Antihypertensive Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Antihypertensive Sales and Growth Rate (2013-2018)
Figure North America Antihypertensive Revenue and Growth Rate (2013-2018)
Table North America Antihypertensive Sales by Countries (2013-2018)
Table North America Antihypertensive Sales Market Share by Countries (2013-2018)
Figure North America Antihypertensive Sales Market Share by Countries in 2013
Figure North America Antihypertensive Sales Market Share by Countries in 2017
Table North America Antihypertensive Revenue by Countries (2013-2018)
Table North America Antihypertensive Revenue Market Share by Countries (2013-2018)
Figure North America Antihypertensive Revenue Market Share by Countries in 2013
Figure North America Antihypertensive Revenue Market Share by Countries in 2017
Figure United States Antihypertensive Sales and Growth Rate (2013-2018)
Figure Canada Antihypertensive Sales and Growth Rate (2013-2018)
Figure Mexico Antihypertensive Sales and Growth Rate (2013-2018)
Figure Europe Antihypertensive Revenue and Growth Rate (2013-2018)
Table Europe Antihypertensive Sales by Countries (2013-2018)
Table Europe Antihypertensive Sales Market Share by Countries (2013-2018)
Table Europe Antihypertensive Revenue by Countries (2013-2018)
Figure Europe Antihypertensive Revenue Market Share by Countries in 2016
Figure Europe Antihypertensive Revenue Market Share by Countries in 2017
Figure Germany Antihypertensive Sales and Growth Rate (2013-2018)
Figure UK Antihypertensive Sales and Growth Rate (2013-2018)
Figure France Antihypertensive Sales and Growth Rate (2013-2018)
Figure Russia Antihypertensive Sales and Growth Rate (2013-2018)
Figure Italy Antihypertensive Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Antihypertensive Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Antihypertensive Sales by Countries (2013-2018)
Table Asia-Pacific Antihypertensive Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Antihypertensive Sales Market Share by Countries 2017
Table Asia-Pacific Antihypertensive Revenue by Countries (2013-2018)
Figure Asia-Pacific Antihypertensive Revenue Market Share by Countries 2017
Figure China Antihypertensive Sales and Growth Rate (2013-2018)
Figure Japan Antihypertensive Sales and Growth Rate (2013-2018)
Figure Korea Antihypertensive Sales and Growth Rate (2013-2018)
Figure India Antihypertensive Sales and Growth Rate (2013-2018)
Figure Southeast Asia Antihypertensive Sales and Growth Rate (2013-2018)
Figure South America Antihypertensive Revenue and Growth Rate (2013-2018)
Table South America Antihypertensive Sales by Countries (2013-2018)
Table South America Antihypertensive Sales Market Share by Countries (2013-2018)
Figure South America Antihypertensive Sales Market Share by Countries in 2017
Table South America Antihypertensive Revenue by Countries (2013-2018)
Table South America Antihypertensive Revenue Market Share by Countries (2013-2018)
Figure South America Antihypertensive Revenue Market Share by Countries in 2017
Figure Brazil Antihypertensive Sales and Growth Rate (2013-2018)
Figure Argentina Antihypertensive Sales and Growth Rate (2013-2018)
Figure Colombia Antihypertensive Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Antihypertensive Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Antihypertensive Sales by Countries (2013-2018)
Table Middle East and Africa Antihypertensive Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Antihypertensive Sales Market Share by Countries in 2017
Table Middle East and Africa Antihypertensive Revenue by Countries (2013-2018)
Table Middle East and Africa Antihypertensive Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Antihypertensive Revenue Market Share by Countries in 2013
Figure Middle East and Africa Antihypertensive Revenue Market Share by Countries in 2017
Figure Saudi Arabia Antihypertensive Sales and Growth Rate (2013-2018)
Figure UAE Antihypertensive Sales and Growth Rate (2013-2018)
Figure Egypt Antihypertensive Sales and Growth Rate (2013-2018)
Figure Nigeria Antihypertensive Sales and Growth Rate (2013-2018)
Figure South Africa Antihypertensive Sales and Growth Rate (2013-2018)
Table Global Antihypertensive Sales by Type (2013-2018)
Table Global Antihypertensive Sales Share by Type (2013-2018)
Table Global Antihypertensive Revenue by Type (2013-2018)
Table Global Antihypertensive Revenue Share by Type (2013-2018)
Figure Global Diuretics Sales Growth (2013-2018)
Figure Global Diuretics Price (2013-2018)
Figure Global Angiotensin receptor blockers (ARBs) Sales Growth (2013-2018)
Figure Global Angiotensin receptor blockers (ARBs) Price (2013-2018)
Figure Global Angiotensin converting enzyme (ACE) inhibitors Sales Growth (2013-2018)
Figure Global Angiotensin converting enzyme (ACE) inhibitors Price (2013-2018)
Figure Global Beta blockers Sales Growth (2013-2018)
Figure Global Beta blockers Price (2013-2018)
Figure Global Alpha blockers Sales Growth (2013-2018)
Figure Global Alpha blockers Price (2013-2018)
Figure Global Calcium channel blockers Sales Growth (2013-2018)
Figure Global Calcium channel blockers Price (2013-2018)
Figure Global Renin inhibitors Sales Growth (2013-2018)
Figure Global Renin inhibitors Price (2013-2018)
Figure Global Vasodilators Sales Growth (2013-2018)
Figure Global Vasodilators Price (2013-2018)
Table Global Antihypertensive Sales by Application (2013-2018)
Table Global Antihypertensive Sales Share by Application (2013-2018)
Figure Global Clinic Sales Growth (2013-2018)
Figure Global Home Sales Growth (2013-2018)
Figure Global Antihypertensive Sales, Revenue and Growth Rate (2018-2023)
Table Global Antihypertensive Sales Forecast by Regions (2018-2023)
Table Global Antihypertensive Market Share Forecast by Regions (2018-2023)
Figure North America Sales Antihypertensive Market Forecast (2018-2023)
Figure Europe Sales Antihypertensive Market Forecast (2018-2023)
Figure Asia-Pacific Sales Antihypertensive Market Forecast (2018-2023)
Figure South America Sales Antihypertensive Market Forecast (2018-2023)
Figure Middle East and Africa Sales Antihypertensive Market Forecast (2018-2023)
Table Global Antihypertensive Sales Forecast by Type (2018-2023)
Table Global Antihypertensive Market Share Forecast by Type (2018-2023)
Table Global Antihypertensive Sales Forecast by Application (2018-2023)
Table Global Antihypertensive Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
  • Global Bone Graft Substitute Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 21-Nov-2018        Price: US 3480 Onwards        Pages: 115
    Bone substitutes can be broadly categorized into bone grafts (autograft, allograft, xenograft), ceramics (hydroxyapatite, TCP, calcium sulphate) and growth factors (DBM, PRP, BMP'S) Scope of the Report: The worldwide market for Bone Graft Substitute is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study. This report focuses on the Bone ......
  • Global Oncology Adjuvants Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 21-Nov-2018        Price: US 3480 Onwards        Pages: 118
    Oncology Adjuvant treatment is a cancer therapy, which involves cancer treatment after the primary treatment is completed. Oncology adjuvants treatment mainly reduces the reoccurrence of cancer. Scope of the Report: The worldwide market for Oncology Adjuvants is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study. This report focuses on......
  • Global Oncology Drug Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 21-Nov-2018        Price: US 3480 Onwards        Pages: 122
    Drugs used for oncology. Scope of the Report: The worldwide market for Oncology Drug is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study. This report focuses on the Oncology Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on ma......
  • Global Ophthalmic Viscosurgical Devices Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 21-Nov-2018        Price: US 3480 Onwards        Pages: 115
    Ophthalmic viscosurgical devices (OVDs) are used in cataract surgery as a viscoelastic solution to create and maintain space in the anterior chamber of the eye. OVDs have generally been used during phacoemulsification, implantation of intraocular lens, to protect corneal endothelium, and as a coating to surgical instruments. OVDs are transparent, gel like viscous substances having elastic properties. OVDs have properties of both fluids and solids. The differentiating feature in OVDs can be becau......
  • Global Oral Antidiabetic Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 21-Nov-2018        Price: US 3480 Onwards        Pages: 122
    Diabetes mellitus is a group of a metabolic disorder caused when the body is unable to produce required quantity of Insulin. Insulin is a hormone secreted by beta cells of the islet of Langerhans of the pancreas. Various symptoms associated with diabetes disorder include recurrent urination, increased thirst, and hunger. Diabetes can cause much chronic complication if left untreated. Some of them include acute complications like diabetic ketoacidosis, chronic kidney failure, foot ulcers, and dam......
  • Global Polymerase Chain Reaction (PCR) Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 21-Nov-2018        Price: US 3480 Onwards        Pages: 124
    Polymerase chain reaction (PCR) is a technology that has opened up new vistas for advances in life sciences research and molecular diagnostics due to its attributes, such as detection and quantification of DNA and RNA genetic materials. Scope of the Report: The worldwide market for Polymerase Chain Reaction (PCR) is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Glo......
  • Global Parkinson's Disease Therapeutics Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 21-Nov-2018        Price: US 3480 Onwards        Pages: 116
    Parkinson's disease is a type of progressive movement disorder, characterized by muscle rigidity, and tremors. Scope of the Report: The worldwide market for Parkinson's Disease Therapeutics is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study. This report focuses on the Parkinson's Disease Therapeutics in global market, especially in ......
  • Global Pathology Imaging Systems Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 21-Nov-2018        Price: US 3480 Onwards        Pages: 118
    Pathology imaging system uses the latest technology of scanners and software for digitizing the slides for pathological examinations. It has replaced the traditional pathology workflow of slides and microscope. Scope of the Report: The worldwide market for Pathology Imaging Systems is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study. ......
  • Global Patients Handling Equipment Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 21-Nov-2018        Price: US 3480 Onwards        Pages: 115
    Patient handling equipment market is expected to witness significant growth due to growing acceptance of these equipment owing to their wide array of applications. Rising prevalence of disabilities and high adoption rate of these equipment to cater needs of patients has led their increased usage. Scope of the Report: The worldwide market for Patients Handling Equipment is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs